DuPont Introduces Higher-Adhesion, Low-Cyclics Silicone Soft Skin Adhesive
Recently, DuPont announced the launch of new DuPont™ Liveo™ MG 7-9960 soft skin adhesive. The higher-adhesion, low-cyclics silicone soft skin adhesive (SSA) is designed for use in advanced wound care dressings and for adhering medical devices to the skin for long-term wear and gentle removal.
DuPont™ Liveo™, a globally recognized leader in silicone technology for medical devices, defines the critical quality attributes of silicone skin adhesives. These technologies are already widely used in the advanced wound care and scar treatment markets, and now DuPont will further strengthen its existing product series with this new SSA solution.
New DuPont™ Liveo™ MG 7-9960 soft skin adhesive has the highest peel adhesion of the Liveo™ SSA family, enabling better fit, painless removal, re-application, and improved durability Wear resistance and design flexibility. In addition, low-ring Liveo™ MG 7-9960 SSA is non-allergenic, non-irritating and non-cytotoxic, making it ideal for protecting sensitive and fragile skin of children, the elderly and patients with dermatological diseases or open wounds.
DuPont developed this adhesive as part of its efforts to expand its portfolio of solutions to support the growing medical device market. The adhesive also enables manufacturers to fine-tune performance to meet the application requirements of medical device designers by adjusting coating weight.
"As difficult-to-heal wounds become more common and wound healing rates need to improve, we are looking to expand our portfolio of medical-grade adhesive solutions and work with medical device OEMs and processors to support their development of new dressings or Wearable design." said Jennifer Gemo, global strategic marketing leader for DuPont™ Liveo™ Healthcare Solutions.
"Because customers have unique medical device designs and processes, it is critical not only to supply high-quality, high-performance materials but also to support customers in optimizing their product development," Said Audrey Wipret, technical services and development specialist and medical device expert of DuPont™ Liveo™ Healthcare Solutions in Europe, the Middle East and Africa.
2026-09-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Can the Manufacturing Sector Withstand Dow’s April Polyethylene Price Doubling?
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
NHU and Sinopec Advance Liquid Methionine Project
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
ADNOC Advances Covestro Deal Amid EU Subsidy Probe
-
BASF and Zhejiang University Forge Innovation Partnership
-
Mitsui Chemicals Restarts TDI Plant After Accident Shutdown
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
LB Group Takes Over UK Titanium Dioxide Plant, Restarts 150,000-tonne Capacity
Recommend Reading
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Thirteen Years of Partnership Ends: SK Group Bids Farewell to Sinopec-SK Wuhan Petrochemical
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Mitsubishi Gas Chemical Suspends Construction of MXDA Plant in the Netherlands
-
China's urea market shows a strong upward trend (8.17-8.21)
-
Methanol Market Partially Rises
-
This Week's PVC Prices Show Narrow Fluctuations (9.15-19)
-
This week, sodium metabisulfite prices rose in China (8.17-8.21)
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI